While it becomes increasingly more difficult to reach prescribers, MediScripts has the unique ability to target advertisements, getting the brand message into their hands and generating proven ROI
Hasbrouck Heights, NJ (PRWEB) August 07, 2012
MediScripts, a point-of-prescription advertising medium, today announced that the company has named Jim Pantaleo as Executive Vice President, Sales and Marketing. Pantaleo joins MediScripts with more than 20 years in the industry, offering strong expertise in pharmaceutical sales, management and marketing communications.
“Jim’s impressive knowledge and experience managing integrated marketing campaigns for some of the industry’s biggest brands will help take MediScripts to the next level,” said Erez Lapsker, Chief Executive Officer of MediScripts. “He joins an already strong team, and we look forward to growing the MediScripts brand.”
In his new role, Pantaleo is responsible for directing the day-to-day sales and business activities for MediScripts. He will also oversee the preparation and implementation of short and long-term business plans including new digital offerings designed to keeps brands top of mind with its base of 150,000 prescribers.
“I am thrilled to join such a talented group of individuals, and look forward to helping advance MediScripts product offerings,” said Pantaleo. “While it becomes increasingly more difficult to reach prescribers, MediScripts has the unique ability to target advertisements, getting the brand message into their hands and generating proven ROI.”
Pantaleo previously served as Vice President of Sales and Marketing for Haymarket Media, Inc., where he led strategic programs for Monthly Prescribing Reference to create new revenue streams across numerous specialties including primary care, urology, long-term care, pharmacy, hematology and oncology.
MediScripts is a point-of-prescription advertising medium that puts brand messages at the center of prescriber-patient engagement. With a database of more than 150,000 prescribers, MediScripts delivers precise targeting by decile, by specialty and by market. And because it’s a paid subscription service, MediScripts is PhRMA Code compliant. In over 50 brand-specific IMPACT studies performed by Wolters Kluwer Health, MediScripts on average delivers over a 20:1 return on investment. For more information, visit http://www.mediscripts.com.
# # #